Adjuvant Sorafenib for Liver Cancer: Wrong Stage, Wrong Dose
The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(15)00296-x
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 1, 2015
Authors
Publisher
Elsevier BV
Available in full text
October 1, 2015
Elsevier BV